The strategic determination of when to administer agents designed to stimulate the pituitary gland’s release of endogenous growth hormone (GH), such as GHRH analogs or ghrelin mimetics. Optimal timing is critical because GH secretion naturally occurs in nocturnal pulses, and external stimulation must align with the physiological readiness of the somatotrophs to maximize therapeutic effect.
Origin
This practice stems from clinical endocrinology research focused on maximizing the anabolic and lipolytic effects of GH while minimizing potential side effects associated with constant elevation. It is a refinement of GH replacement or augmentation strategies.
Mechanism
Effective secretagogue timing leverages the body’s natural readiness state, often targeting the pre-sleep period when endogenous GH pulses are strongest and GHIH (somatostatin) suppression is naturally favored. Proper timing ensures that the pharmacological signal synergizes with the inherent circadian machinery regulating somatotroph function.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.